J
JNJ
JNJReviewed5 segments tracked|6 years of data|Annual (10-K)
Total Revenue
$89.2B488.2%
FY2024
Operating Segments
5Active segments
Blended Margin
25.4%Operating margin
Highest Margin
33.2%Innovative Medicine
Segment Shift
Innovative Medicine has grown from 0.0% to 63.8% of total revenue since FY2019, with 33.2% operating margins. Meanwhile, Med Tech is the fastest growing at +776.9% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Innovative Medicine | $57.0B | $18.9B | 33.2% | 63.8% | +393.7% |
| Med Tech | $31.9B | $3.7B | 11.7% | 35.7% | +776.9% |
| Pharmaceutical | $418M | $0 | 0.0% | 0.5% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free